The Hepatitis B Foundation’s Regional Biotech Council presented its 12th Annual RBC Conference, “Biotech Success Stories of the Region ” on Friday, October 12, 2012.
Pat Higgins, Former Executive Vice President, Commercial, Pharmasset, Inc., “A Revolutionary Treatment for Hepatitis C Affords Blockbuster Biotech Deal”
Loren Danzis, Partner, Fox Rothschild, “New Trends in Venture Capital Financing amongst Life Science Companies”
Nick Spring, Former CEO of Topaz Pharmaceuticals, Currently CEO of Rainbow Rx, “Ivermectin, a Sensational Natural Product for Animals and Man”
Jim Datin, EVP and Managing Director, Safeguard, "The Success of Avid Pharmaceuticals from an Investor's Point of View"
The Hepatitis B Foundation’s Regional Biotech Council presented
its annual RBC Conference, 2011: A Biospace Odyssey”
Exploration of Natural Products through Public/Private Partnerships on Friday, October 28, 2011.
Roy Vagelos, M.D., Retired Chairman and CEO of Merck & Co., Inc., “Merck Experience in Drug Discovery”
Craig Hopp, Ph.D., Program Officer at NCCAM-National Institutes of Health, “Natural Products, Nutraceuticals and NCCAM: A First Hand Account of an Evolving Industry”
Ilya Raskin, Ph.D., Founder and Partner, Nutrasorb, “Developing Novel Botanical Products for Metabolic Syndrome”
Dennis Stevenson, Ph.D., Vice President, New York Botanical Garden, "Expeditions in Phytoprospecting: From the Field to Genomics"
Michael Goetz, Ph.D., Director, Natural Products Discovery Institute, IHVR, “Perspectives on Natural Product Research and the NPDI”
The Hepatitis B Foundation’s Regional Biotech Council presented its annual RBC Conference, Commercializing University Technologies on Friday, October 1, 2010.
Robert McGrath, Ph.D., Associate Vice Provost for Entrepreneurship and Technology Commercialization Drexel University
Katherine Chou, M.B.A., Executive Director, Office of Technology Transfer and Business Development, Thomas Jefferson University
Ned Heindel, Ph.D., Professor of Chemistry, Lehigh University
Stephen Chadwick, President and CEO - Secant Medical
Gary Jacob, Ph.D., President and CEO – Synergy Pharmaceuticals
The Hepatitis B Foundation’s Regional Biotech Council presented its annual RBC Conference, A Roadmap for Biotechnology Ventures on Friday, September 18, 2009.
Hon. Representative Patrick Murphy, U.S. Congress, 8th District
Senator Chuck McIlhinney, Pennsylvania State Senate, 10th District
Mr. Loren D. Danzis, Partner, Fox Rothschild, LLP.
Ms. Jennifer Hart, Ben Franklin Technology Partners of SEPA, Director of Investments & Life Sciences
Dr. Joseph Kim, CEO, Inovio Biomedical Corporation
Mr. Neal McCarthy, Managing Director of Fairmount Partners
Ms. Jennifer Miller, Ballard Spahr Andrews & Ingersoll, LLP
Dr. Salvatore J. Salamone, CEO & Chief Scientific Officer, Saladax Biomedical, Inc.
Dr. Robert A. Zivin, Corporate Director, Johnson and Johnson Corporate Office of Science & Technology
The Hepatitis B Foundation’s Regional Biotech Council presented its annual RBC Conference,Commercializing Academic Discoveries on Friday, October 10, 2008. The Regional Biotech Council Award was awarded to Dr. Eli Mordechai.
Dr. Dennis Cheek, Vice President of Education, Ewing Marion Kauffman Foundation
Mr. James A. Datin, Executive Vice President & Managing Director, Life Sciences
Dr. Ray Manganelli, Partner, Sagamore Capital
Dr. Richard Caruso, Founder & Chairman, Integra Life Sciences
Ms. Jeannine M. Martilla, Executive Director, Technology Investment Office, Pennsylvania Department
of Community and Economic Development
The Hepatitis B Foundation’s Regional Biotech Council presented its annual “Biotech Award for Outstanding Achievement” to Mr. Paul Raetsch, (Ret.) Director of the Philadelphia Regional Office, U.S. Department of Commerce, Economic Development Administration, at its 7th annual biotech conference.
|(Left to right): Dr. Rifat Pamukcu, Midway Pharma; Mr. James Self, Merck; Dr. Timothy Block, Hepatitis B Foundation; state senator Chuck McIlhinney; Mr. Paul Raetsch, 2007 biotech honoree; Dr. Anthony Green, Ben Franklin Technology Partners of Southeastern PA; Dr. Mohan Philip, Hepatitis B Foundation and Immunotope; and Mr. Ed Erickson, formerly of Immunicon (November 9, 2007).|